These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11484086)

  • 1. Comment--to: Pinizzotto M, Castillo E, Fiaux M, Temler E, Gaillard RC, Ruiz J (2001) Paraoxonase 2 polymorphisms are associated with diabetic nephropathy in Type II diabetes. Diabetologia 44: 104-107.
    Canani LH; Araki S; Warram JH; Krolewski AS
    Diabetologia; 2001 Aug; 44(8):1062-4. PubMed ID: 11484086
    [No Abstract]   [Full Text] [Related]  

  • 2. -to: Pinizzotto M, Castillo E, Fiaux M, Temier E, Gaillard RC, Ruiz J (2001) Paraoxanase 2 polymorphisms are associated with diabetic nephropathy in Type II diabetes. Diabetologia 44: 104-107.
    Hodgkinson AD; Millward BA; Demaine AG
    Diabetologia; 2002 Jun; 45(6):933-5. PubMed ID: 12154776
    [No Abstract]   [Full Text] [Related]  

  • 3. Polymorphisms of human paraoxonase 1 gene (PON1) and susceptibility to diabetic nephropathy in type I diabetes mellitus.
    Araki S; Makita Y; Canani L; Ng D; Warram JH; Krolewski AS
    Diabetologia; 2000 Dec; 43(12):1540-3. PubMed ID: 11151764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraoxonase2 polymorphisms are associated with nephropathy in Type II diabetes.
    Pinizzotto M; Castillo E; Fiaux M; Temler E; Gaillard RC; Ruiz J
    Diabetologia; 2001 Jan; 44(1):104-7. PubMed ID: 11206400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The paraoxonase PON1 promoter polymorphism C(-107)T is associated with increased serum glucose concentrations in non-diabetic patients.
    Leviev I; Kalix B; Brulhart Meynet MC; James RW
    Diabetologia; 2001 Sep; 44(9):1177-83. PubMed ID: 11596674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Met54Leu polymorphism of paraoxonase (PON) enzyme gene is not a genetic risk factor for non-insulin-dependent diabetes mellitus in Finns.
    Malin R; Huang XH; Wirta O; Rantalaiho V; Pasternack A; Jokela H; Koivula T; Lehtimäki T
    Clin Genet; 1998 Sep; 54(3):254-5. PubMed ID: 9788735
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum paraoxonase activity and paraoxonase gene polymorphism in type 2 diabetic patients with or without vascular complications.
    Letellier C; Durou MR; Jouanolle AM; Le Gall JY; Poirier JY; Ruelland A
    Diabetes Metab; 2002 Sep; 28(4 Pt 1):297-304. PubMed ID: 12442067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between M/L55-polymorphism of paraoxonase enzyme and oxidative DNA damage in patients with type 2 diabetes mellitus and in control subjects.
    Malin R; Rantalaiho V; Huang XH; Wirta O; Pasternack A; Leinonen JS; Alho H; Jokela H; Koivula T; Tanaka T; Okada K; Ochi H; Toyokuni S; Lehtimäki T
    Hum Genet; 1999; 105(1-2):179-80. PubMed ID: 10480377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy.
    Mackness B; Durrington PN; Abuashia B; Boulton AJ; Mackness MI
    Clin Sci (Lond); 2000 Mar; 98(3):355-63. PubMed ID: 10677395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes.
    Pfohl M; Koch M; Enderle MD; Kühn R; Füllhase J; Karsch KR; Häring HU
    Diabetes; 1999 Mar; 48(3):623-7. PubMed ID: 10078566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraoxonase (Gln192-Arg) polymorphism in French type 2 diabetics.
    Helbecque N; Cottel D; Meirhaeghe A; Dallongeville J; Amouyel P
    Atherosclerosis; 1999 Dec; 147(2):415-6. PubMed ID: 10627268
    [No Abstract]   [Full Text] [Related]  

  • 12. Paraoxonase 2 (PON2) polymorphisms and development of renal dysfunction in type 2 diabetes: UKPDS 76.
    Calle R; McCarthy MI; Banerjee P; Zeggini E; Cull CA; Thorne KI; Wiltshire S; Terra S; Meyer D; Richmond J; Mancuso J; Milos P; Fryburg D; Holman RR
    Diabetologia; 2006 Dec; 49(12):2892-9. PubMed ID: 17096118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic risk factor for the onset and progression of diabetic complication].
    Nakajima K; Tanaka Y
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():95-101. PubMed ID: 12430213
    [No Abstract]   [Full Text] [Related]  

  • 14. Apolipoprotein E polymorphism and the progression of diabetic nephropathy in type 2 diabetes.
    Tien KJ; Tu ST; Chou CW; Yang CY; Hsiao JY; Shin SJ; Chen HC; Hsieh MC
    Am J Nephrol; 2011; 33(3):231-8. PubMed ID: 21346330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A search for association between the polymorphic markers of PON1 and PON2 genes and diabetic nephropathy in patients with type I diabetes mellitus].
    Voron'ko OE; Iakunina NIu; Shestakova MV; Zotova EV; Chugunova EV; Shamkhalova MSh; Vikulova OK; Debabov VG; Dedov VG; Nosikov VV
    Genetika; 2005 Jun; 41(6):844-9. PubMed ID: 16080611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter polymorphism T(-107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic patients.
    James RW; Leviev I; Ruiz J; Passa P; Froguel P; Garin MC
    Diabetes; 2000 Aug; 49(8):1390-3. PubMed ID: 10923642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.
    Garin MC; James RW; Dussoix P; Blanché H; Passa P; Froguel P; Ruiz J
    J Clin Invest; 1997 Jan; 99(1):62-6. PubMed ID: 9011577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic factors with significance in pathogenesis of diabetic nephropathy--the role of polymorphism of renin-angiotensin system genes].
    Grzeszczak W
    Przegl Lek; 2000; 57 Suppl 3():19-24. PubMed ID: 11293230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro12Ala polymorphism in the PPARG gene contributes to the development of diabetic nephropathy in Chinese type 2 diabetic patients: comment on the study by Liu et al.
    Lapice E; Pinelli M; Riccardi G; Vaccaro O
    Diabetes Care; 2010 Aug; 33(8):e114; author reply e115. PubMed ID: 20668149
    [No Abstract]   [Full Text] [Related]  

  • 20. Paraoxonase 1 polymorphisms (L55M and Q192R) as a genetic marker of diabetic nephropathy in youth with type 1 diabetes.
    Fekih O; Triki S; Rejeb J; Neffati F; Douki W; Ommezzine A; Chouchane S; Guediche MN; Bouslama A; Najjar MF
    Endokrynol Pol; 2017; 68(1):35-41. PubMed ID: 26884296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.